ALK and lung cancer: Mass spectrometry (MS) coupled with anti-phosphotyrosine antibodies identified different patterns of tyrosine kinase signaling in lung cancer cells and tumors, and this approach was able to identify cells driven by oncogenic EGFR, PDGFR, and ALK [4].